| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5955562 | Chest | 2012 | 7 Pages |
Abstract
New use of short- and long-acting β-agonists may slightly increase the risk of cardiac arrhythmia in patients with COPD. It remains unclear whether ipratropium bromide also increases this risk, despite the use of a larger study population.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Machelle PhD, Pierre MD, James M. MD, PhD, Robert W. PhD, Samy PhD,